1. Home
  2. GOSS vs EVF Comparison

GOSS vs EVF Comparison

Compare GOSS & EVF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.37

Market Cap

101.2M

Sector

Health Care

ML Signal

HOLD

Logo Eaton Vance Senior Income Trust

EVF

Eaton Vance Senior Income Trust

HOLD

Current Price

$4.98

Market Cap

95.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOSS
EVF
Founded
2015
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
101.2M
95.9M
IPO Year
2018
1998

Fundamental Metrics

Financial Performance
Metric
GOSS
EVF
Price
$0.37
$4.98
Analyst Decision
Buy
Analyst Count
8
0
Target Price
$4.19
N/A
AVG Volume (30 Days)
12.3M
85.9K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$48,471,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$147.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.32
$4.77
52 Week High
$3.87
$5.78

Technical Indicators

Market Signals
Indicator
GOSS
EVF
Relative Strength Index (RSI) 28.37 48.91
Support Level $0.33 N/A
Resistance Level $0.60 $5.04
Average True Range (ATR) 0.04 0.06
MACD 0.06 0.01
Stochastic Oscillator 30.41 84.62

Price Performance

Historical Comparison
GOSS
EVF

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About EVF Eaton Vance Senior Income Trust

Eaton Vance Senior Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide a high level of current income consistent with the preservation of capital, by investing in senior, secured floating-rate loans. The trust invests in below-investment-grade floating-rate loans, which are considered speculative because of the credit risk of their issuers. Its portfolio of investment consists of aerospace and defense, automotive, beverage, building and development, business equipment and services, cable and satellite television, and other areas.

Share on Social Networks: